Koers HedgePath Pharmaceuticals Inc
Aandelen
US42278K1025
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13-12-22 |
James McNulty
DFI | Director of Finance/CFO | 73 | 13-12-22 |
Amy M. McCord
LAW | General Counsel | - | 01-01-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13-12-22 |
Samuel Sears
BRD | Director/Board Member | 80 | 02-08-13 |
Ronald Osman
BRD | Director/Board Member | 78 | 23-08-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |